SCHEMBL6990430

SCHEMBL6990430

CC(CCNC(=O)c1ccc(-n2cccn2)cc1)CC(=O)NC1(C)C(=O)COC1C

nearest known ligand 0.41

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
GCGR P47871 2/20 0.41
DGAT1 O75907 2/20 0.40
KDM1A O60341 12/20 0.38
HRH3 Q9Y5N1 1/20 0.36
ELOVL6 Q9H5J4 1/20 0.35
DRD2 P14416 1/20 0.34
HTR2A P28223 1/20 0.34
DRD3 P35462 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6985875 0.83 LMNA (0.40)
SCHEMBL6989326 0.82 RAB9A (0.38)
SCHEMBL6985259 0.81 HDAC1 (0.40) DRD2DRD3
SCHEMBL6985955 0.81 NAMPT (0.37) GCGR
SCHEMBL6987790 0.81 TAS1R3 (0.38) DRD2DRD3
SCHEMBL6751665 0.79 KDM1A (0.42) KDM1A
SCHEMBL6987802 0.79 KMT2A (0.41)
SCHEMBL6986287 0.79 CHRM4 (0.39) DRD2HTR2A
SCHEMBL6985501 0.78 GCGR (0.41) GCGRDGAT1KDM1AELOVL6
SCHEMBL6986218 0.78 TRPV1 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1362042-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES Amura Therapeutics Limited (GB) 2003-11-19 EP disclosed
WO-2002057249-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES AMURA THERAPEUTICS LIMITED (GB) 2002-07-25 WO disclosed